|
Listen to this text  |
The Carina surgical robotic system. | Source: Ronovo Surgical
Ronovo Surgical introduced at this time that it closed a brand new spherical of financing, bringing its complete funds raised to greater than $50 million since 2020.
Shanghai-based Ronovo develops broad, cross-specialty robotic-assisted surgical procedure (RAS) know-how. LongRiver Investments led the newest financing spherical. Existing buyers Lilly Asia Ventures, Vivo Capital, Matrix Partners China and GGV Capital participated. CEC Capital acted because the unique monetary advisor.
Ronovo stated it now exits “stealth mode,” unveiling its inaugural Carina robotic platform. Carina, a modular system constructed on proprietary know-how, allows configurable robotic help for laparoscopic surgical procedures throughout a number of specialties.
Add Ronovo to a bunch of corporations, massive and small, which can be in search of to tackle Intuitive within the soft-tissue robotic surgical procedure house. (Here are 16 surgical robotics corporations it is advisable to know.)
The firm stated its oversubscribed financing spherical accelerates the multi-discipline scientific trial for Carina. It additionally expects the funds to strengthen R&D and scientific functions improvement, in addition to bolster its expertise base.
Robotics Summit & Expo (May 10-11) returns to Boston
More about Ronovo Surgical and its Carina system
Ronovo developed Carina in collaboration with famend Chinese laparoscopic surgeons, in line with a information launch. It addresses quite a few ache factors in minimally invasive surgical procedures and offers surgeons with the flexibleness to decide on one of the best devices and probably the most excellent anatomical entry. As such, surgeons can leverage prior laparoscopic coaching and enhance upon their surgical efficiency, the corporate stated.
The firm famous that Carina minimizes tools footprint to maximise the utilization of working room house. Surgical groups can select between three-module or four-module configurations, Ronovo stated. Surgeons even have a full suite of devices from which to decide on with Carina.
“We are extremely grateful to our investors for their confidence in Ronovo’s strategy to democratize robotic surgery,” stated Dr. John Ma, founder, chair and CEO of Ronovo. “From inception, we have stayed true to our belief that innovation must start from an original pursuit to solve actual unmet clinical needs.”
Editor’s Note: This article first appeared on sister web site MassDevice.